Hormonal therapy in the form of combination oral contraceptive
pills has been shown to help treat both inflammatory acne lesions (the papules, pustules and painful nodules under the skin), and non-inflammatory acne lesions (blackheads and whiteheads).
Efficacy and safety of a low-dose monophasic combination oral contraceptive
containing 100 microg levonorgestrel and 20 microg ethinyl estradiol (Alesse).
A combination oral contraceptive
containing drospirenone, a progestin, and ethinyl estradiol, a form of estrogen, was recently approved by the FDA.
Escape' ovulation in women due to the missing of low dose combination oral contraceptive
Quartette[TM] is an investigational extended regimen combination oral contraceptive
in development for the prevention of pregnancy.
Obesity and combination oral contraceptive
agents are independent risk factors for venous thromboembolism (VTE).
Miller L and Notter KM, Menstrual reduction with extended use of combination oral contraceptive
pills: randomized controlled trial, Obstetrics & Gynecology, 2001, 98(5, pt.
Cigarette smoking increases the risk of serious cardiovascular events from combination oral contraceptive
The 19-member panel debated a proposal submitted by Ortho-McNeil Pharmaceutical, a subsidiary of Johnson & Johnson, to develop a combination oral contraceptive
/ folic acid product.
Munro and his colleagues at Kaiser Permanente randomized 40 women with acute uterine bleeding, defined as excessively heavy or prolonged bleeding that was not related to pregnancy, to receive either medroxyprogesterone acetate, 20 mg three times a day for 7 days, and then 20 mg a day for 3 weeks, or combination oral contraceptive
treatment with norethindrone (1 mg) and ethinyl estradiol (35 mcg) in one tablet three times a day for 7 days, followed by one tablet a day for 3 weeks.
One low-dose estrogen/progestin combination oral contraceptive
under development is moving in a direction some women have already undertaken with available products.
No new safety concerns were raised by a review of adverse events reported during a recent 1-year period in adolescents taking a combination oral contraceptive
, according to Jean Wendy Temeck, M.